NCT01447667View on ClinicalTrials.gov

Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Hepatic FibrosisHepatocellular Carcinoma
Interventions
PROCEDURE

Magnetic resonance elastography

Magnetic resonance elastography before RFA and Liver biopsy of 2 HCC tissue and 2 non tumor liver parenchyma tissue

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01447667 - Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) | Biotech Hunter | Biotech Hunter